Investor Relations

Zosano Pharma is an emerging CNS company focusing on providing rapid symptom relief to patients, using known therapeutics with well-established safety and efficacy, but altering their delivery profile using the Company’s proprietary transdermal delivery system. The Company’s goal is to make transdermal drug delivery a standard of care for delivering drugs requiring fast onset of action.

NASDAQ: ZSAN
1.35
- 0.02 (-1.47%)
Day High: 1.40
Day Low:  1.31
Volume:    142,418
11:55 AM ET on May 25, 2017

Delayed at least 20 minutes.